Maternal and neonatal outcomes and prognostic factors in acute fatty liver of pregnancy

• DOI: 10.1016/j.ejogrb.2020.06.052
• Publication Date: 2020-06-26T17:01:47Z
• Authors: Y. Joueidi; K. Peoc’h; M. Le Lous; G. Bouzille; C. Rousseau; E. Bardou-Jacquet; C. Bendavid; L. Damaj; B. Fromenty; V. Lavoué; C. Moreau
• Keywords: Male; [SDV]Life Sciences [q-bio]; Infant, Newborn; Metabolic disease; Fetal and maternal outcomes; Acute fatty liver of pregnancy; Prognosis; 3. Good health; Fatty Liver; Pregnancy Complications; 03 medical and health sciences; 0302 clinical medicine; Swansea criteria; Liver; Pregnancy; Humans; Female; Delivery; Retrospective Studies

To report complications of Acute Fatty Liver of pregnancy (AFLP), a rare liver disease of pregnancy, and identify prognostic factors for mothers and children.We conducted a retrospective descriptive study over 18 years in three French maternities. Demographic, clinical, biological data, and outcomes of patients and their infants were reviewed.142,450 pregnancies from centers were studied. Eighteen patients with AFLP were identified The prevalence of AFLP was estimated as 1/7,914 pregnancies. Prolonged prothrombin time was identified as a risk factor of maternal complications (OR = 0.86, p = 0.0493). Gestational age at delivery was the only risk factor associated with fetal or neonate complications (OR = 0.37, p = 0.0417). One boy died of previously undiagnosed β-oxidation deficiency at eight months.In AFLP, prothrombin time must be carefully monitored to anticipate major maternal complications. Infants born to mothers with ALFP should be screened as early as possible for mitochondrial fatty acid oxidation deficiency.